We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Tricuspid valve endocarditis in the era of the opioid epidemic.
- Authors
Wallen, Tyler J.; Szeto, Wilson; Williams, Matthew; Atluri, Pavan; Arnaoutakis, George; Fults, Marci; Sultan, Ibrahim; Desai, Nimesh; Acker, Michael; Vallabhajosyula, Prashanth
- Abstract
<bold>Background and Aim: </bold>We reviewed our institutional experience with tricuspid valve endocarditis to understand the impact of the opioid epidemic on the incidence of right heart endocarditis.<bold>Methods: </bold>We retrospectively reviewed all cases of tricuspid endocarditis managed surgically from January of 2011 to May of 2017. There were no exclusion criteria.<bold>Results: </bold>A total of 126 patients were identified. There were seven cases in 2011 and 36 in 2016. The average age of the patients decreased from 52.85 ± 19.6 years in 2011 to 39.2 ± 12.9 in 2017. Caucasians comprised 71% of the patients in 2011 and 75% in 2016. Tricuspid valve replacement was performed in 74 patients (58.73%) and repair was performed in 52 (41.27%). Thirty-day mortality was 11.11%. Reoperation, stroke and renal failure requiring dialysis during the index hospitalization were 5.6%, 0.8%, and 8%, respectively. Staphylococcus aureus, found in 43% of cases, was the most common isolate throughout the study period. Streptococcus was the second most common causative agent.<bold>Conclusions: </bold>In a span of 5 years, our institution has noted a fivefold increase in surgical volume for tricuspid endocarditis, most likely related to the impact of the opioid epidemic.
- Subjects
TRICUSPID valve diseases; ENDOCARDITIS; OPIOIDS; HEMODIALYSIS; HOSPITAL care; AGE distribution; CARDIAC surgery; INFECTIVE endocarditis; STAPHYLOCOCCUS aureus; STREPTOCOCCUS; SUBSTANCE abuse; TIME; TRICUSPID valve; RETROSPECTIVE studies
- Publication
Journal of Cardiac Surgery, 2018, Vol 33, Issue 5, p260
- ISSN
0886-0440
- Publication type
journal article
- DOI
10.1111/jocs.13600